Non-isothermal and isothermal cold crystallization of glass-forming chiral smectic liquid crystal (S)-4′-(1-methyloctyloxycarbonyl) biphenyl-4-yl 4-[7-(2,2,3,3,4,4,4-heptafluorobutoxy) heptyl-1-oxy]-benzoate

被引:24
|
作者
Drzewicz, Anna [1 ]
Juszynska-Galazka, Ewa [1 ]
Zajac, Wojciech [1 ]
Piwowarczyk, Marcin [1 ]
Drzewinski, Witold [2 ]
机构
[1] Polish Acad Sci, Inst Nucl Phys, PL-31342 Krakow, Poland
[2] Mil Univ Technol, Inst Chem, Kaliskiego 2, PL-00908 Warsaw, Poland
关键词
Liquid aystals; Cold crystallization; Differential scanning calorimetry; Polarized optical microscopy; Fourier transform infrared spectroscopy; DFT calculations; DIELECTRIC-RELAXATION; MOLECULAR-DYNAMICS; KINETICS; PHASE; TEMPERATURE; BEHAVIOR; POLYMORPHISM; TRANSITIONS;
D O I
10.1016/j.molliq.2020.114153
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The mesomorphic behaviour as well as the kinetics of the isothermal and non-isothermal cold crystallization of the liquid-like smectic SmCA* phase in (S)-4'-(1-methyloctyloxycarhonyl) biphenyl-4-yl 4-[7-(2,2,3,3,4,4,4-heptalluorobutoxy) heptyl-1-oxy]-benzoate (3F7HPhH7) were studied using differential scanning calorimetry, polarized optical microscopy and Fourier transform infrared spectroscopy supported by quantum chemical NT calculations. The process of cold crystallization under isothermal conditions was treated in terms of Avrami and Avrami-Avramow models, and under non-isothermal conditions it was described by Ozawa, Mo, Kissinger and Augis-Bennett models. Non-isothermal cold crystallization of the 3F7HPhH7 compound was achieved by two different mechanisms: one depending on diffusion rates (for slow heating) and second one based on the nucleation process (for fast heating). The activation energy of non-isothermal cold crystallization was found equal to 130 and 50 kJ/mol for slow and fast heating, respectively. Cold crystallization under isothermal conditions depends primarily on diffusion rates with the activation energy equalled 133 kl/mol. The obtained values of the Avrami exponent n(A) and the Ozawa exponent n(o) suggest that the crystal growth is three-dimensional. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] (S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-2H-1-benzopyran-3-yl]phenyl 2,2-dimethylpropanoate (EM-800): A highly potent, specific, and orally active nonsteroidal antiestrogen
    Gauthier, S
    Caron, B
    Cloutier, J
    Dory, YL
    Favre, A
    Larouche, D
    Mailhot, J
    Ouellet, C
    Schwerdtfeger, A
    Leblanc, G
    Martel, C
    Simard, J
    Merand, Y
    Belanger, A
    Labrie, C
    Labrie, F
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (14) : 2117 - 2122
  • [22] Crystal structure of 3-(2-chloro-benzyl)-7-[4-(2-chloro-benzyl)-piperazin-1-yl]-5,6,8-trifluoro-3H-quinazolin-4-one, C26H21Cl2F3N4O
    Fang, Shu-Fen
    Peng, Wen-Wen
    Xiong, Yuan-Zhen
    Nie, Xu-Liang
    Huang, Jian-Ping
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2021, 236 (04): : 815 - 817
  • [23] Synthesis, characterization, crystal structure and Hirshfeld surface analysis of a hexahydroquinoline derivative: tert-butyl 4-([1,1′-biphenyl]-4-yl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
    Yildirim, Sema Ozturk
    Akkurt, Mehmet
    Cetin, Gokalp
    Simsek, Rahime
    Butcher, Ray J.
    Bhattarai, Ajaya
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2022, 78 : 798 - +
  • [24] Synthesis and crystal structure of poly[aqua(μ4-(1R,2S,4R)-4-hydroxy-1-((7-hydroxy-3-(4-hydroxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl)methyl)pyrrolidin-1-ium-2-carboxylate-κ4O:O′:O":O"')sodium(I)] monohydrate, C21H22NNaO12S
    Chen, Hai-Lin
    Huang, Xiu-Xiang
    Lan, Jian-Jing
    Yao, Dong-Mei
    Wang, Yan-Ping
    Liu, Qiu-Ping
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2022, 237 (04): : 733 - 735
  • [25] Crystal structure of (E)-2-(5,5-dimethyl-3-(4-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)oxy)styryl) cyclohex-2-en-1-ylidene)malononitrile, C25H19N5O4
    Huang, Haiqing
    Xu, Li
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (05): : 1073 - 1075
  • [26] CRYSTAL-STRUCTURE OF (5S)-2-[(1R,2S,3R,4S)-3-(2,2-DIMETHYLPROPOXY)-1,7,7-TRIMETHYLBICYCLO-[2.2.1]HEPTYL-2-OXY]-7-OXABICYCLO[3.3.0]OCT-1-EN-3-ONE, C22H34O4
    ALVAREZLARENA, A
    PINIELLA, JF
    VERDAGUER, X
    MOYANO, A
    PERICAS, MA
    RIERA, A
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE, 1993, 203 : 107 - 109
  • [27] Synthesis, crystal structure and absolute configuration of (3aS,4R,5S,7aR)-7-(but-3-en-1-yn-1-yl)-2,2-dimethyl-3a,4,5,7a-tetrahydro-2H-1,3-benzodioxole-4,5-diol
    de Abreu Lima, Alejandro Peixoto
    Pandolfi, Enrique
    Schapiro, Valeria
    Suescun, Leopoldo
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2024, 80 : 1165 - +
  • [28] Crystal structure of (-)-7-[(7S)-7-amino-5-azaspiro [2,4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid (sitafloxacin) sesquihydrate
    Suzuki, T
    Kitaoka, H
    Miwa, Y
    Taga, T
    ANALYTICAL SCIENCES, 2000, 16 (03) : 343 - 344
  • [29] R(-)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl)-2,1,3-benzoxadiazole, a fluorescent chiral tagging reagent:: sensitive resolution of chiral amines and amino acids by reversed-phase liquid chromatography
    Toyo'oka, T
    Jin, D
    Tomoi, N
    Oe, T
    Hiranuma, H
    BIOMEDICAL CHROMATOGRAPHY, 2001, 15 (01) : 56 - 67
  • [30] Crystal structure of (S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-3-methoxy-6-oxopyridazin-1(6H)-yl)-3-phenylpropanamido)benzoic acid monohydrate, C29H26ClN3O7
    Xu, Wen-Jie
    Xiao, Ying
    Tan, Duan-Ming
    Li, Song
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2024, 239 (05): : 945 - 947